Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Abstract
The past decades have seen a revolution in our understanding of brain diseases and in particular of drug addiction. This has been largely due to the identification of neurotransmitter receptors and the development of animal models, which together have enabled the investigation of brain functions from the molecular to the cognitive level. Tobacco smoking, the principal - yet avoidable - cause of lung cancer is associated with nicotine addiction. Recent studies in mice involving deletion and replacement of nicotinic acetylcholine receptor subunits have begun to identify the molecular mechanisms underlying nicotine addiction and might offer new therapeutic strategies to treat this addiction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These receptors appear early in development and are functionally active in the fetal brain to mediate many critical aspects of brain maturation [1–4].”
From Nicotine on the developing brain. (2023) · cites this paper as [1]
In the citing paper
“Nicotine, the primary psychoactive component of tobacco, activates nicotinic acetylcholine receptors (nAChRs), pentameric ligand-gated ion channels which are widely distributed throughout the brain [1,2].”
From Nicotine on the developing brain. (2023) · cites this paper as [1]
In the citing paper
“Nicotine usurps the action of endogenous acetylcholine (ACh) by signaling through nicotinic acetylcholine receptors (nAChRs), a diverse family of pentameric ligand-gated cation channels [52].”
From Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks (2025) · cites this paper as [52]
In the citing paper
“The primary nAChRs in CNS dopaminergic systems that mediate the addictive effects of nicotine are the ␣42* and ␣62* subtypes”
From Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum (2012) · cites this paper as Changeux, 2010
In the citing paper
“a region implicated in the rewarding and addictive effects of nicotine (Wise, 2009;Changeux, 2010).”
From Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum (2012) · cites this paper as Changeux, 2010
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785
Getting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
The prefontral cortex and cognitive control
Miller, E. K. (2000) · Nature Reviews Neuroscience · doi:10.1038/35036228 · Cited by 2,016
Seguela, P., Wadiche, J., Dineley-Miller, K., Dani, J., & Patrick, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
A study of the ‘desensitization’ produced by acetylcholine at the motor end‐plate
Katz, B., & Thesleff, S. (1957) · The Journal of Physiology · doi:10.1113/jphysiol.1957.sp005838 · Cited by 1,461
The control of firing pattern in nigral dopamine neurons: burst firing
Grace, A., & Bunney, B. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-11-02877.1984 · Cited by 1,344
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationLateral habenula as a source of negative reward signals in dopamine neurons
Matsumoto, M., & Hikosaka, O. (2007) · Nature · doi:10.1038/nature05860 · Cited by 1,292
Research works printed but not linked: 1
- Tolu, S. et al. A versatile system for the neuronal subtype specific expression of lentiviral vectors. FENS Forum of European Neuroscience (Amsterdam, the Netherlands). Abstract 07549 (2010).
Cited by
Items 201–300 of 457
Wei, Z., Belal, C., Tu, W., Chigurupati, S., Ameli, N. J., Lu, Y., & Chan, S. L. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0326 · Cited by 24
“nAChRs that differ in subunit composition differ in pharmacology, conductance, and kinetics as well as in their permeability to and modulation by calcium [33].”
InfluentialRecent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism
Rahman, S., Engleman, E. A., & Bell, R. L. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.004 · Cited by 29
12 h abstinence-induced right anterior insula network pattern changes in young smokers
Bi, Y., Zhang, Y., Li, Y., Yu, D., Yuan, K., & Tian, J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.02.019 · Cited by 26
Thompson, M. F., Poirier, G. L., Dávila‐García, M. I., Huang, W., Tam, K., Robidoux, M., Dubuke, M. L., Shaffer, S. A., Colón-Pérez, L. M., Febo, M., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117719265 · Cited by 25
“The brain structures differentially affected in the present study, including the ventral tegmental area, are mostly widely implicated in addiction processes (Changeux, 2010; Koob and Volkow, 2009).”
BackgroundLewis, A. S., & Picciotto, M. R. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107929 · Cited by 23
“Nicotinic acetylcholine receptors are a diverse group of ionotropic cation channels broadly expressed throughout the central and peripheral nervous systems (Baddick and Marks, 2011; Changeux, 2010) in multiple brain areas known to be important in the direct regulation of aggression as well as in processes related to a…”
BackgroundBesson, M., Guiducci, S., Granon, S., Guilloux, J., Guiard, B. P., Repérant, C., Fauré, P., Pons, S., Cannazza, G., Zoli, M., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4362-2 · Cited by 27
Multidimensional Intersection of Nicotine, Gene Expression, and Behavior
Sherafat, Y., Bautista, M. R., & Fowler, C. D. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.649129 · Cited by 28
Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder
Pastor, V. E., Antonelli, M. C., & Pallarés, M. E. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9674-9 · Cited by 22
“Mesocorticolimbic circuit is broadly modulated by several neurotransmission systems, such as cholinergic (Changeux 2010; de Kloet et al. 2015; Faure et al. 2014; Mark et al. 2011), GABAergic (Kudo et al. 2012), serotoninergic (Alex and Pehek 2007), noradrenergic (Jenner et al. 1983) Fig.”
BackgroundInfluentialCuny, H., Yu, R., Tae, H., Kompella, S. N., & Adams, D. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13852 · Cited by 25
“…implicated in neurological disorders such as Parkinson’s disease, Alzheimer’s disease, schizophrenia, Tourette’s syndrome and epilepsy, as well as opiate and nicotine addiction (Lindstrom, 1997; Ripoll et al., 2004; Dani and Bertrand, 2007; Changeux, 2010; Hurst et al., 2013; Muldoon et al., 2014).”
BackgroundKim, J., Yang, J. H., Ryu, I. S., Sohn, S., Kim, S., & Choe, E. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122943 · Cited by 22
Cameli, C., Bacchelli, E., Paola, M. D., Giucastro, G., Cifiello, S., Collo, G., Cainazzo, M. M., Pini, L. A., Maestrini, E., & Zoli, M. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0223-2 · Cited by 24
Deflorio, C., Blanchard, S., Carisi, M. C., Bohl, D., & Maskos, U. (2016) · The FASEB Journal · doi:10.1096/fj.201600932r · Cited by 23
Husson, M., Harrington, L., Tochon, L., Cho, Y. H., Ibáñez-Tallon, I., Maskos, U., & David, V. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0356-19.2020 · Cited by 29
“Although the roles of widely expressed nAChR subtypes, like b 2-containing (b 2*) and a7* nAChRs have been largely investigated this past decade (Changeux, 2010; Picciotto and Mineur, 2014), much less work has been conducted on a5*, a3*, and b4* nAChRs encoded by the CHRNA5-CHRNA3-CHRNB4 gene cluster, in which genetic…”
BackgroundVázquez-Gómez, E., Arias, H. R., Feuerbach, D., Miranda‐Morales, M., Mihailescu, S., Targowska‐Duda, K. M., Jóźwiak, K., & García‐Colunga, J. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.059 · Cited by 24
Xu, R., Luo, M., Xia, R., Meng, X., Xu, X., Xu, Z., Cheng, J., Shao, X., Li, H.-J., & Li, Z. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf504014y · Cited by 21
Jordan, C. J., & Xi, Z.-X. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.811192 · Cited by 20
“Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels composed of α (α2–α7, α9, and α10) and β (β2–β4) subunits that co-assemble in various combinations with distinct functional properties (Changeux, 2010).”
BackgroundNicotine Alters the Proteome of Two Human Pancreatic Duct Cell Lines
Paulo, J. A. (2014) · PubMed · doi:10.6092/1590-8577/2559 · Cited by 20
“Nicotine interacts with a population of nicotinic acetylcholine receptors (nAChR), with varying affinities and downstream effectors [10] and as such is as a contributing factor to myocardial [11, 12] , atrial [13], pulmonary [14, 15] and biliary fibrosis [16] diseases.”
BackgroundZiółkowska, B., Kiełbiński, M., Gieryk, A., Sòria, G., Maldonado, R. J., & Przewłocki, R. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0583-z · Cited by 23
“Recent advances in generation of genetically modified mouse lines have yielded powerful tools for studying multiple genes and pathways that could be involved in drug addiction (Changeux 2010; Kieffer and Gavériaux-Ruff 2002; Sora et al. 2010; Stephens et al. 2002).”
BackgroundDawson, A., Miles, M. F., & Damaj, M. I. (2013) · Alcohol · doi:10.1016/j.alcohol.2012.12.004 · Cited by 23
Fisher, S. K., & Wonnacott, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00013-4 · Cited by 27
Nicotinic receptors as SARS-CoV-2 spike co-receptors?
Dormoy, V., Perotin, J., Gosset, P., Maskos, U., Polette, M., & Deslée, G. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110741 · Cited by 21
Cross‐species analysis of nicotine‐induced proteomic alterations in pancreatic cells
Paulo, J. A., Urrutia, R. A., Kadiyala, V., Banks, P. A., Conwell, D. L., & Steen, H. (2013) · PROTEOMICS · doi:10.1002/pmic.201200492 · Cited by 19
“Nicotine interacts with a broad population of nicotinic acetylcholine receptors (nAChR), with varying affinities and downstream effectors [23, 24].”
BackgroundRötering, S., Deuther‐Conrad, W., Cumming, P. D., Donat, C. K., Scheunemann, M., Fischer, S., Xiong, G., Steinbach, J., Peters, D., Sabri, O., et al. (2014) · EJNMMI Research · doi:10.1186/s13550-014-0043-5 · Cited by 19
“Background The homomeric α7 nicotinic acetylcholine receptor (α7 nAChR), together with the heteromeric α4β2 nAChR, belongs to the cysteine-loop family of ligand-gated ion channels and they represent the two most abundant nAChR populations in the brain [1].”
Morris, M., Shaw, A., Lambert, M., Perry, H. H., Lowenstein, E. G., Valenzuela, D., & Velazquez-Ulloa, N. A. (2018) · BMC Developmental Biology · doi:10.1186/s12861-018-0172-6 · Cited by 20
Potasiewicz, A., Gołębiowska, J., Popik, P., & Nikiforuk, A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118812097 · Cited by 21
Critical Role of Peripheral Actions of Intravenous Nicotine in Mediating Its Central Effects
Lenoir, M., & Kiyatkin, E. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.104 · Cited by 20
Srisontiyakul, J., Kastman, H. E., Krstew, E., Govitrapong, P., & Lawrence, A. J. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2045-3 · Cited by 20
“α4β2* (*indicates the possibility of other subunits) and α7 subunits are the most abundantly expressed nAChR subunits in the brain, and are reported to play key roles in the behavioural effects of nicotine [20].”
Maurer, J. J., Sandager‐Nielsen, K., & Schmidt, H. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4475-7 · Cited by 18
Nicotine Addiction: Mechanisms and Consequences
Rosenthal, D. G., Weitzman, M. L., & Benowitz, N. L. (2011) · International Journal of Mental Health · doi:10.2753/imh0020-7411400102 · Cited by 25
“Nicotine stimulates dopaminergic transmission in the VTA of the midbrain, which in turn activates the nucleus accumbens, an area critical for nicotine-mediated physiological effects such as addiction, pleasure, and reward [10, 11, 18].”
BackgroundMahmood, H. M., Aldhalaan, H., Alshammari, T. K., Alqasem, M., Alshammari, M. A., Albekairi, N. A., & AlSharari, S. D. (2020) · Autism Research · doi:10.1002/aur.2342 · Cited by 19
“The behavioral effects of chronic nicotine treatment may indirectly attribute to promote other neurotransmitters release as well, including glutamate and dopamine [Changeux, 2010; Lambe, Picciotto, & Aghajanian, 2003; Salminen et al., 2004; Wonnacott, 1997].”
BackgroundCorsini, S., Tortora, M., & Nistri, A. (2016) · The Journal of Physiology · doi:10.1113/jp272591 · Cited by 16
Sato, H., Kawano, T., Yin, D. X., Kato, T., & Toyoda, H. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.031 · Cited by 16
Nicotine receptors mediating sensorimotor gating and its enhancement by systemic nicotine
Pinnock, F., Bosch, D., Brown, T. C., Simons, N. S., Yeomans, J. R., DeOliveira, C., & Schmid, S. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00030 · Cited by 19
“The α4β2 nAChR subtype is the most common neuronal non-α7nAChR and it has been shown to be involved in cognitive processing (Changeux, 2010).”
Ren, J., Sun, J., Zhang, Y., Liu, T., Ren, Q., Li, Y., & Guo, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052521 · Cited by 19
“It is known that nicotine acts in the nervous system by activating nAChRs, and some nAChR subunits have been reported to play a critical function in nicotine dependence in mammalian systems [40].”
BackgroundLykhmus, O., Koval, L., Skok, M., Zouridakis, M., Zisimopoulou, P., Tzartos, S. J., Tsetlin, V. I., Granon, S., Changeux, J., Комісаренко, С. В., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101842 · Cited by 16
Self-citationNicotine recruits glutamate receptors to postsynaptic sites
Duan, J.-J., Lozada, A. F., Gou, C., Xu, J., Chen, Y., & Berg, D. K. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.09.002 · Cited by 23
“Numerous studies report that early nicotine exposure has long-lasting behavioral consequences extending into the adult long after nicotine cessation (Albuquerque et al., 2009; Changeux, 2010; Gotti et al. 2009; Heath and Picciotto 2009; Laviolette and van der Kooy, 2004).”
BackgroundUpton, M. K., & Lotfipour, S. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.015 · Cited by 16
“To better understand how these unique receptors contribute to nicotine-modulated behaviors, including withdrawal, genetic animal models have been developed [2, 5, 15, 16].”
BackgroundChi, F., Wang, L., Zheng, X., Jong, A., & Huang, S. (2011) · Future Microbiology · doi:10.2217/fmb.11.65 · Cited by 16
Simmons, S. J., & Gould, T. J. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12171 · Cited by 19
“Genetically engineered b2-knockout (b2 / ) mice have allowed for delineating the involvement of the b2 subunit of neuronal nAChRs in nicotineinduced reward.(58,59) It has been reported that b2 / mice show significantly reduced phasic DA release in the NAcc upon nicotine administration relative to wild-type control ani…”
BackgroundLeSage, M. G., Shelley, D., Pravetoni, M., & Pentel, P. R. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.026 · Cited by 16
Jensen, K. P., Smith, A. H., Herman, A. I., Farrer, L. A., Kranzler, H. R., Sofuoglu, M., & Gelernter, J. E. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.43 · Cited by 17
Hamouda, A. K., Bautista, M. R., Akinola, L. S., Alkhlaif, Y., Jackson, A. B., Carper, M., Toma, W. B., Garai, S., Chen, Y.-C., Thakur, G. A., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108568 · Cited by 16
Yang, J. H., Sohn, S., Kim, S., Kim, J., Oh, J. H., Ryu, I. S., Go, B. S., & Choe, E. S. (2021) · Addiction Biology · doi:10.1111/adb.12913 · Cited by 14
“Nicotine is a psychoactive component of tobacco which stimulates nicotinic acetylcholine receptors (nAChRs) in the brain.(1) These receptors are pentameric ligand-gated ion channels that consist of homoor heteromeric complexes of α and β subunits, and α4β2 and α7 are”
BackgroundHamouda, A. K., Jackson, A. B., Bağdaş, D., & Damaj, M. I. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx183 · Cited by 17
Matera, C., Dondio, G. M., Braida, D., Ponzoni, L., Amici, M. D., Sala, M., & Dallanoce, C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.047 · Cited by 14
“Among the neuronal nicotinic receptors, α4β2* heteromers and α7 homomers are the most abundant subtypes found throughout the CNS (Romanelli et al., 2007; Millar, 2003; Gotti and Clementi, 2004; Corradi and Bouzat, 2016).”
BackgroundInfluentialCHRNA2: a new paradigm in beige thermoregulation and metabolism
Ma, Y., Liu, S., Jun, H., & Wu, J. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.11.009 · Cited by 17
Lee, H., Kang, M., Chung, J.-M., & Noh, J. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.11.034 · Cited by 14
Ryu, I. S., Kim, J., Seo, S. Y., Yang, J. H., Oh, J. H., Lee, D., Cho, H., Lee, K., Yoon, S. S., Seo, J., et al. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00047 · Cited by 15
“For example, repeated exposure to nicotine increases glutamate release in the NAc, VTA and PFC by stimulating nAChRs (Lambe et al., 2003; Changeux, 2010; Shameem and Patel, 2012; Falasca et al., 2014).”
BackgroundBrain Nicotinic Receptors as Emerging Targets for Drug Addiction
Rahman, S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00008-9 · Cited by 15
Mu, X., Wu, W., Wang, S., Su, X., Guan, H., Guan, X., Lu, X., & Li, Z. (2024) · Schizophrenia · doi:10.1038/s41537-024-00449-1 · Cited by 15
Wu, G., Chen, D., Tang, H., Ren, Y., Chen, Q., Lv, Y., Zhang, Z., Zhao, Y., Yao, Y., & Xu, P. (2014) · Molecular Microbiology · doi:10.1111/mmi.12511 · Cited by 13
“…heterocyclic compounds, including nicotine in tobacco wastes and carbazole and its derivatives in wastes from coal gasification plants, are environmental pollutants (Xu et al., 2006; Tang et al., 2008; 2009; 2011), with mutagenic and toxic activities (Jha and Bharti, 2002; Changeux, 2010).”
BackgroundTouchette, J. C., Maertens, J. J., Mason, M. M., O’Rourke, K. Y., & Lee, A. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.019 · Cited by 15
“The nAChRs are well-known to play a critical role in nicotine reinforcement (for reviews, see (Changeux, 2010; de Kloet et al., 2015)).”
Kim, S., Sohn, S., Ryu, I. S., Yang, J. H., Kim, O., Kim, J., Kim, Y., Jang, E. Y., & Choe, E. S. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac063 · Cited by 14
Zhou, Z., Bai, J., Zhong, S., Zhang, R., Kang, K., Zhang, X., Xu, Y., Zhao, C., & Zhao, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1260161 · Cited by 13
Brown, C. E., Sweetnam, D., Beange, M., Nahirney, P. C., & Nashmi, R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4568-11.2012 · Cited by 15
“Studies have shown that nAChRs can regulate synaptic plasticity in the hippocampus and reward pathways (McKay et al., 2007; Nashmi et al., 2007; Changeux, 2010).”
Jiang, L., López‐Hernández, G. Y., Lederman, J., Talmage, D. A., & Role, L. W. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0032 · Cited by 16
“…to selective activation and inhibition of specific nicotinic-type receptors and genetic deletion of nAChR subunits have helped define the many possible types of nicotinic receptor-mediated responses to released ACh (e.g., Picciotto et al., 2001; Wess, 2003; Taly et al., 2009; Changeux, 2010).”
Lee, A. M., Arreola, A. C., Kimmey, B. A., & Schmidt, H. D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.016 · Cited by 14
“There is clear evidence that neuronal nAChRs play critical roles in nicotine reinforcement and withdrawal [4-7], which supports the development of novel smoking cessation pharmacotherapies targeting these receptors.”
BackgroundInteraction of bupropion and zinc with neuronal nicotinic acetylcholine receptors
García‐Colunga, J., Godoy-García, U., & Vázquez-Gómez, E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.009 · Cited by 12
“, 2000; Winzer-Serhan and Leslie, 1997), 3) nAChRs are associated with nicotine dependence, anxiety and depression (Changeux, 2010; Taly et al., 2009), 4) zinc and bupropion have antidepressant-like actions, and 5) zinc enhances the effects of some antidepressants including bupropion (Cunha et al.”
BackgroundInfluentialMadsen, H. B., Koghar, H. S., Pooters, T., Massalas, J. S., Drago, J., & Lawrence, A. J. (2014) · Addiction Biology · doi:10.1111/adb.12148 · Cited by 18
“…dopaminergic projections from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) (Champtiaux et al. 2003; Gotti et al. 2005; Grady et al. 2007; Changeux 2010), a neuronal pathway that is critical for the reinforcing properties of nicotine (Corrigall et al. 1992; Corrigall, Coen & ©…”
BackgroundDesigning Selective Modulators for the Nicotinic Receptor Subtypes: Challenges and Opportunities
Manetti, D., Bellucci, C., Chiaramonte, N., Dei, S., Teodori, E., & Romanelli, M. N. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0169 · Cited by 13
“In many instances the involvement of nAChRs has been evidenced by using knock-out mice [17, 18].”
Semenova, S., Jin, X., McClure‐Begley, T. D., Tadman, M. P., Marks, M. J., & Markou, A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.06.002 · Cited by 13
“To date, 12 neuronal subunits of nAChRs have been identified with nine α-type (α2-α10) and three β-type (β2-β4) receptors that form structurally and functionally distinct hetero- and homo-pentametric receptors (Changeux, 2010; Collins et al., 2009).”
BackgroundGlial cells as therapeutic targets for smoking cessation
Kumar, M., Adeluyi, A., Anderson, E. L., & Turner, J. R. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108157 · Cited by 12
“[PubMed: 30206328] Changeux J-P, 2010 Nicotine addiction and nicotinic receptors: lessons from genetically modified mice.”
BackgroundMasukawa, D., Nishizawa, D., Kanai, K., Kitamura, S., Kasahara, Y., Hashimoto, T., Takahagi, R., Hasegawa, J., Nakayama, K., Sato, N., et al. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.003 · Cited by 12
Drug Addiction: From Neuroscience to Ethics
Farisco, M., Evers, K., & Changeux, J.-P. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00595 · Cited by 14
“, a moving from self-awareness to unchecked goal-directed actions (36).”
BackgroundSelf-citationHaller, G., Li, P., Esch, C., Hsu, S., Goate, A., & Steinbach, J. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096753 · Cited by 14
“This is, perhaps, expected as mice lacking the b4 subunit only show alterations in nicotine withdrawal symptoms and decreased adverse effects at high nicotine doses compared to wild-type, suggesting that even large effects on protein level may have small effects on behavior [28].”
Prenatal Nicotine Increases Matrix Metalloproteinase 2 (MMP-2) Expression in Fetal Guinea Pig Hearts
Thompson, L. P., Liu, H., Evans, L. C., & Mong, J. A. (2011) · Reproductive Sciences · doi:10.1177/1933719111404605 · Cited by 11
Epigenetic Mechanisms Mediate Nicotine-Induced Reward and Behaviour in Zebrafish
Faillace, M. P., & Bernabeu, R. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210716112351 · Cited by 11
“Repeated administration of nicotine upregulates nAChR subunits [11, 135].”
Impact of Nicotine on Cognition in Patients With Schizophrenia: A Narrative Review
Spasova, V., Mehmood, S., Minhas, A., Azhar, R., Anand, S., Abdelaal, S., Sham, S., Chauhan, T. M., & Dragas, D. (2022) · Cureus · doi:10.7759/cureus.24306 · Cited by 15
“The nAChR subunits α2, α3, α4, α5, α7, β2, and β4 are likely to mediate the cognitive effects of nicotine, and, as mentioned below, the best evidence is for the implication of the α7 and β2 subunits [38,39].”
BackgroundJones, S. K., Wolf, B. J., Froeliger, B., Wallace, K., Carpenter, M. J., & Alberg, A. J. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109596 · Cited by 13
Keeley, R. J., Prillaman, M. E., Scarlata, M., Vrana, A., Tsai, P.-J., Gomez, J. L., Bonaventura, J., Lu, H., Michaelides, M., & Stein, E. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac291 · Cited by 15
Hammad, A. M., Alhusban, A. A., Alzaghari, L. F., Alasmari, F. F., & Sari, Y. (2023) · Metabolites · doi:10.3390/metabo13040515 · Cited by 15
“Nicotine increases dopamine neurotransmission at least in part through modulating nAChRs in the brain [66].”
Backgroundde Bruin, N. M. W. J., Kloeze, B. M., & McCreary, A. C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.045 · Cited by 11
Protein dynamics and the allosteric transitions of pentameric receptor channels
Changeux, J. (2014) · Biophysical Reviews · doi:10.1007/s12551-014-0149-z · Cited by 11
“…(Changeux et al. 1970; Miledi et al. 1971 ; Karlin 1993; for review, Changeux 2012b). nAChRs are involved in many brain processes and diseases, such as attention, learning and memory, access to consciousness, nicotine addiction and Alzheimer and Parkinson diseases (for review, Changeux 2006, 2010).”
Self-citationThe Lock is the Key: Development of Novel Drugs through Receptor Based Combinatorial Chemistry
Šinko, G., & Maraković, N. (2017) · Acta chimica slovenica · doi:10.17344/acsi.2016.3134 · Cited by 11
Paulo, J. A., & Gygi, S. P. (2018) · PROTEOMICS · doi:10.1002/pmic.201700475 · Cited by 10
Forget, B., Icick, R., Robert, J., Correia, C., Prevost, M. S., Gielen, M. C., Corringer, P., Bellivier, F., Vorspan, F., Besson, M., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101898 · Cited by 12
“…ligand-gated ion channels composed of α (α2– α7, α9, α10) and β (β2– β4) 81 subunits that co-assemble according to various combinations with distinct brain localizations and 82 functional properties (Changeux, 2010). nAChRs have been investigated in preclinical models of 83 cocaine addiction.”
BackgroundZhu, Y., Yang, J., Yeh, F., Cole, S. A., Haack, K., Lee, E. T., Howard, B. V., & Zhao, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102220 · Cited by 12
“[23] Polymorphisms in genes encoding nAChRs have been associated with nicotine dependence [24] and lung cancer.”
BackgroundEpigenetics, Brain and Behavior
Sassone‐Corsi, P., & Christen, Y. (2012) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-27913-3 · Cited by 11
How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science
Jensen, K. P., DeVito, E. E., & Sofuoglu, M. (2016) · Tobacco Regulatory Science · doi:10.18001/trs.2.4.14 · Cited by 12
Pech, U., Janssens, J., Schoovaerts, N., Kuenen, S., Calatayud, C., Gallego, S. F., Makhzami, S., Hulselmans, G. J., Poovathingal, S. K., Davie, K., et al. (2024) · eLife · doi:10.1101/2023.03.11.532176 · Cited by 18
Reynolds, L. M., Gulmez, A., Fayad, S. L., Campos, R. C., Rigoni, D., Nguyen, C., Le Borgne, T., Topilko, T., Rajot, D., Franco, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53327-w · Cited by 10
Role of neuronal nicotinic acetylcholine receptors in cannabinoid dependence
Buzzi, B., Köşeli, E., Moncayo, L. V., Shoaib, M., & Damaj, M. I. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106746 · Cited by 11
Nicotine Motivated Behavior in C. elegans
Salim, C., Batsaikhan, E., Kan, A. K., Chen, H., & Jee, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031634 · Cited by 10
“Functional nAChRs are homopentameric or heteropentameric channels composed of fi ve subunits by a combination of the α ( α 2– α 10) and β ( β 2– β 4) subunits [28,50–52].”
BackgroundYang, J., Zhu, Y., Lee, E. T., Zhang, Y., Cole, S. A., Haack, K., Best, L. G., Devereux, R. B., Roman, M. J., Howard, B. V., et al. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.963967 · Cited by 10
Kim, S., Sohn, S., & Choe, E. S. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac034 · Cited by 11
“Nicotine upregulates glutamate release by stimulating nicotinic acetylcholine receptors (nAChRs) in the terminals of the neurons in the caudate and putamen (CPu), a component of the basal ganglia involving habit learning such as cigarette smoking (Yin and Knowlton, 2006; Changeux, 2010; Ryu et al., 2017).”
BackgroundAltered neurochemical levels in the rat brain following chronic nicotine treatment
Falasca, S., Ranc, V., Petruzziello, F., Khani, A., Kretz, R., Zhang, X., & Rainer, G. (2014) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2014.05.002 · Cited by 11
“So far, a growing body of evidence has demonstrated that chronic nicotine administration alters several neurochemical circuits, for example affecting glutamate and gamma aminobutyric acid (GABA) levels in the ventral tegmental area (VTA) (Changeux, 2010), glutamate levels in the prefrontal cortex (Shameem and Patel, 2…”
InfluentialSynaptic Epigenesis and the Evolution of Higher Brain Functions
Changeux, J. (2012) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-27913-3_2 · Cited by 14
“These observations suggest that nicotine may also act directly on white matter and there is electrophysiological evidence that supports a direct action of nicotine on axon conduction, possibly at the level of the node of Ranvier (reviewed in Changeux 2010).”
BackgroundSelf-citationCollo, G., Cavalleri, L., Zoli, M., Maskos, U., Ratti, E., & Pich, E. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00572 · Cited by 10
“These nicotine concentrations were compatible with the exposure reached in vivo and associated with behavioral effects in rodents (Changeux, 2010).”
BackgroundA novel effect of PDLIM5 in α7 nicotinic acetylcholine receptor upregulation and surface expression
Li, Z.-L., Gou, C., Wang, W., Li, Y., Cui, Y., Duan, J.-J., & Chen, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04115-y · Cited by 10
Overnight deprivation from smoking disrupts amygdala responses to fear
Onur, O. A., Patin, A., Mihov, Y., Buecher, B., Stoffel‐Wagner, B., Schlaepfer, T. E., Walter, H., Maier, W., & Hurlemann, R. (2011) · Human Brain Mapping · doi:10.1002/hbm.21293 · Cited by 10
“Nicotine addiction critically differs from other drug addictions such as opioid, cocaine, or alcohol addiction by the absence of severe somatic withdrawal/negative affect symptoms [Changeux, 2010].”
BackgroundStress Response Genes and the Severity of Nicotine Withdrawal
Jensen, K. P., & Sofuoglu, M. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.149 · Cited by 10
Kaneko, S., Niki, Y., Yamada, K., Nasukawa, D., Ujihara, Y., & Toda, K. (2022) · Molecular Brain · doi:10.1186/s13041-022-00959-y · Cited by 15
“other tissues of many organisms, and have been associated with a wide range of behavioral symptoms [1, 2].”
BackgroundInfluentialRasmi, Y., Shokati, A., Hatamkhani, S., Farnamian, Y., Naderi, R., & Jalali, L. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2506 · Cited by 9
“141 Earlier types of coronaviruses affected the olfactory route to transport as retrograde current in nerves.”
BackgroundCheng, H., Fan, C., Zhang, S.-W., Wu, Z., Cui, Z., Melcher, K., Zhang, C., Jiang, Y., Cong, Y., & Xu, H. E. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.34 · Cited by 10
Zhou, Y., Li, C., Li, R., & Zhou, C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26295 · Cited by 11
“Neural network theory involved in nicotine addiction has proposed that the switch from voluntary nicotine use to compulsive drug use may represent dysfunction of higher level cognition (Changeux, 2010).”
BackgroundDeba, F., Munoz, K., Peredia, E., Akk, G., & Hamouda, A. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101455 · Cited by 9
“nicotine, the major addictive component of tobacco smoking, and are considered a major molecular target for pharmacotherapeutic interventions tomanage nicotine dependence (6, 7).”
BackgroundSofuoglu, M., Herman, A. I., Robinson, C. D., & Waters, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00012-5 · Cited by 11
López, J. J., Pérez, E. G., & García‐Colunga, J. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.09.016 · Cited by 8
Lee, H., Jang, M., Kim, W., & Noh, J. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4636-3 · Cited by 9
Neurobiological Considerations for Tobacco Use Disorder
Chawla, M., & Garrison, K. A. (2018) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-018-0168-3 · Cited by 12
Metadata
- Authors
- Changeux, J.-P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Changeux, Jean-Pierre
- Venue
- Nature Reviews Neuroscience
- Published
- 2010-06
- Volume
- 11
- Issue
- 6
- Pages
- 389-401
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2014016697
- Cited by
- 453
- References
- 148
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 30 · 2019: 23 · 2018: 29 · 2017: 25 · 2016: 32 · 2015: 36 · 2014: 47 · 2013: 34 · 2012: 44
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centre National de la Recherche Scientifique
- Ipsen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotine dependence, nicotinic acetylcholine receptors, nicotinic receptor subunits, transgenic mice, smoking, drug addiction
- MeSH terms
- Animals, Behavior, Animal, Central Nervous System, Disease Models, Animal, Humans, Mice, Transgenic, Models, Biological, Models, Molecular, Neural Pathways, Nicotine, Receptors, Nicotinic, Reward, Tobacco Use Disorder, Gene Expression, Protein Subunits, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.